Glens Falls Hospital Selects Omnicell Medication Management Solutions to Support Improved Quality of Care and Patient Experience
New Medication Management Systems Support Ongoing Innovation and Collaboration between Nursing and Pharmacy
MOUNTAIN VIEW, Calif., Oct. 3, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Glens Falls Hospital will implement Omnicell's solutions for medication management to help improve workflows for pharmacy and nursing at its 300-bed facility in Glens Falls, New York. The partnership will support Glens Falls' mission to maximize efficiency, support best practice clinical workflows and focus on patient care initiatives by providing reliable, automated systems for effectively managing medications throughout the hospital.
As the United States healthcare industry transitions to a value-based reimbursement model, enriching the patient experience while reducing time spent on manual processes becomes critical. Implementing Omnicell solutions will help enhance hospital patient safety while reducing hours spent on menial tasks, leaving more time for patient care.
"During our recent selection process for an automated dispensing system, we recognized the importance of having a partner who could insure interoperability with our EMR system as well as provide efficiency, quality and safety within our workflow," said Nancy Huntington, Pharmacy Director at Glens Falls Hospital.
Glens Falls will be implementing Omnicell® XT Series Automated Dispensing Cabinets for the safe and efficient dispensing of medications on hospital floors. The XT system features seamless interoperability with the hospital's existing Cerner electronic health record system, which creates greater efficiency for nursing by removing redundant tasks during medication administration. The hospital will be adding the XT Anesthesia Workstation™ in operating rooms to allow for secure storage and timely access of medications, and Central Pharmacy Manager software to support automated management and increased visibility of medication inventory. To help prevent drug diversion, which can have serious patient safety consequences, Glens Falls will also be implementing Controlled Substance Manager, a system that integrates with the automated dispensing cabinets, and Omnicell Analytics, web-based software that provides insights into potential drug diversion activity.
"We were honored to be chosen by Glens Falls in its decision to upgrade medication management solutions throughout the hospital," said J. Christopher Drew, president of North American Automation and Analytics at Omnicell. "Their forward-thinking stakeholders in pharmacy, nursing, and IT were searching for reliable, innovative solutions, and we are excited to be able to offer them products in our portfolio that will serve their needs. We look forward to continuing to partner with Glens Falls to solve additional challenges in the future."
About Glens Falls Hospital
Glens Falls Hospital (GFH) is the largest hospital between Albany, NY and Montreal, Canada and maintains a service area that spans 6,000 square miles across 5 diverse counties. Founded in 1897, GFH today operates an advanced health care delivery system featuring 24 regional facilities including 9 specialty practices and 10 primary care centers. A vast array of specialized medical and surgical services are provided in addition to coronary care, occupational and behavioral health care, rehabilitation and wellness and others. The main hospital campus is home to the C.R. Wood Cancer Center, the Joyce Stock Snuggery birthing center, the Breast Center and a chronic wound healing center. GFH is a not-for-profit organization and the largest employer in New York's Adirondack region, with over 2,700 staff and more than 300 affiliated physicians. For more information visit www.GlensFallsHospital.org.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
SOURCE Omnicell, Inc.
Share this article